The cost of Rinvoq (upadacitinib) for eczema can vary significantly. Without insurance, a one-month supply can range from approximately $5,500 to $6,000 [1].
How can I reduce the cost of Rinvoq?
For eligible individuals with commercial insurance, Rinvoq offers a savings program. This program can potentially reduce out-of-pocket costs to as low as $0 per month, with a maximum annual saving of $13,000 [2]. There are also patient assistance programs available for those who meet specific criteria, which may offer further financial support [1].
What is Rinvoq used for besides eczema?
Rinvoq is approved for the treatment of several other autoimmune conditions. These include moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, and atopic dermatitis in adults and children [3].
When does Rinvoq's patent expire?
The patent expiration timeline for Rinvoq is complex and subject to various factors, including different patent filings for the drug and its uses. Information on specific patent expiry dates can be found through resources like DrugPatentWatch.com [4].
What are the alternatives to Rinvoq for eczema?
Besides Rinvoq, other treatment options for moderate to severe atopic dermatitis exist. These include other JAK inhibitors like Cibinqo (abrocitinib) and different classes of medications such as topical corticosteroids, topical calcineurin inhibitors, Dupixent (dupilumab), and biologics like Adbry (tralokinumab) [3][5]. The choice of treatment depends on the severity of the condition and individual patient factors.